Florbetaben NUZZLE tracer figures to be presented at Alzheimer’s Friendship ICAD 2010
Bayer HealthCare Pharmaceuticals, Inc. today announced that information on the company’s investigational CARESS amyloid imaging tracer Florbetaben (BAY 94-9172) make be presented at the Alzheimer’s Federation Universal Symposium on Alzheimer’s Ailment (Alzheimer’s Affiliation ICAD) 2010 in Honolulu July 10 – 15.
The Florbetaben figures wishes be presented in two voiced presentations and in a bill introduction during the bona fide Alzheimer’s League ICAD well-organized program, as nicely as in four placard presentations during the Alzheimer’s Imaging Consortium (AIC) preconference, representing which Bayer is a co-sponsor. The AIC choose in together the world’s primary imaging and non-imaging researchers to blurred on the clinical request and methodological evolution of neuroimaging to Alzheimer’s condition, other dementias and exact form understanding aging.
"At Bayer, we are committed to investing in molecular imaging into to escape develop the comprehensive value of diagnosis and firm take charge of," said Barbara Putz, MD, Fever pitch of Pandemic Clinical Evolvement, Molecular Imaging, Bayer. "We are in seventh heaven that matter on Florbetaben hand down be the convergence of different presentations during this year’s ICAD meeting."
The Florbetaben observations being presented at the Alzheimer’s Connection ICAD 2010 are:
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
